Chatziralli I,Theodossiadis G,Chatzirallis A,Parikakis E,Mitropoulos P,Theodossiadis P .2018 .Ranibizumab for retinal vein occlusion: predictive factors and long-term outcomes in real-life data. Retina, 38(3) : 559-68.
Iosseliani DG,Bosha NS,Sandodze TS,Azarov AV,Semitko SP .2020 .The effect of revascularization of the internal Carotid artery on the Microcirculation of the eye. J Adv Pharm Educ Res, 10(2) : 209-14.
Dhyani A,Kumar G. .2019 .A New Vision to Eye: Novel Ocular Drug Delivery System. Pharmacophore, 10(1) : 13-20.
Spaide RF,Yannuzzi LA,Sisco LJ .1993 .Chronic cystoid macular edema and predictors of visual acuity. Ophthalmic Surg, : .
Varma R,Bressler NM,Suñer I,Lee P,Dolan CM,Ward J .2012 .Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. Ophthalmology, 05(10) : 2108-18.
Rhoades W,Dickson D,Nguyen QD,Do DV .2017 .Management of macular edema due to central retinal vein occlusion-the role of aflibercept. Taiwan J Ophthalmol, 7(2) : 70-6.
Ogura Y,Roider J,Korobelnik JF,Holz FG,Simader C,SchmidtErfurth U .2014 .Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO study. Am J Ophthalmol, 07(5) : 1032-8.
Wolf-Schnurrbusch UE,Ghanem R,Rothenbuehler SP,Enzmann V,Framme C .2011 .Wolf S. Predictors of short-term visual outcome after antiVEGF therapy of macular edema due to central retinal vein occlusion. Invest Ophthalmol Vis Sci, 10(6) : 6097-7.
Krasniqi M,Trebicka B .2020 .Visual impairment and quality of life, a cross-sectional study. Int J Psychosoc Rehabil, 24(07) : 10234-40.